These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20637220)

  • 41. A label-free biosensor assay for botulinum neurotoxin B in food and human serum.
    Ferracci G; Marconi S; Mazuet C; Jover E; Blanchard MP; Seagar M; Popoff M; Lévêque C
    Anal Biochem; 2011 Mar; 410(2):281-8. PubMed ID: 21134347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Guo JP; An HJ; Zhang SM; Wang S; Yu WY; Sun ZW
    Vaccine; 2013 May; 31(20):2427-32. PubMed ID: 23583890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of botulinum neurotoxin serotype B at sub mouse LD(50) levels by a sandwich immunoassay and its application to toxin detection in milk.
    Scotcher MC; Cheng LW; Stanker LH
    PLoS One; 2010 Jun; 5(6):e11047. PubMed ID: 20548779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR; Rees J; Liu SM; Acharya KR
    J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccines against botulism.
    Karalewitz AP; Barbieri JT
    Curr Opin Microbiol; 2012 Jun; 15(3):317-24. PubMed ID: 22694934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of Botulinum neurotoxin inactivation of nerve function.
    Shoemaker CB; Oyler GA
    Curr Top Microbiol Immunol; 2013; 364():179-96. PubMed ID: 23239354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
    Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
    Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.
    Schmidt JJ; Stafford RG
    Appl Environ Microbiol; 2003 Jan; 69(1):297-303. PubMed ID: 12514008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
    Pellett S; Tepp WH; Scherf JM; Johnson EA
    PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of immunodetection system for botulinum neurotoxin serotype E.
    Sarita R; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain.
    Avril A; Miethe S; Popoff MR; Mazuet C; Chahboun S; Rasetti-Escargueil C; Sesardic D; Thullier P; Hust M; Pelat T
    BMC Biotechnol; 2015 Sep; 15():86. PubMed ID: 26382731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A natural human IgM antibody that neutralizes botulinum neurotoxin in vivo.
    Adekar SP; Al-Saleem FH; Elias MD; Rybinski KA; Simpson LL; Dessain SK
    Hybridoma (Larchmt); 2008 Apr; 27(2):65-9. PubMed ID: 18642670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and characterization of a novel botulinum neurotoxin.
    Zhang S; Masuyer G; Zhang J; Shen Y; Lundin D; Henriksson L; Miyashita SI; Martínez-Carranza M; Dong M; Stenmark P
    Nat Commun; 2017 Aug; 8():14130. PubMed ID: 28770820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM.
    Košenina S; Martínez-Carranza M; Davies JR; Masuyer G; Stenmark P
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology.
    von Berg L; Stern D; Pauly D; Mahrhold S; Weisemann J; Jentsch L; Hansbauer EM; Müller C; Avondet MA; Rummel A; Dorner MB; Dorner BG
    Sci Rep; 2019 Apr; 9(1):5531. PubMed ID: 30940836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specificity of botulinum protease for human VAMP family proteins.
    Yamamoto H; Ida T; Tsutsuki H; Mori M; Matsumoto T; Kohda T; Mukamoto M; Goshima N; Kozaki S; Ihara H
    Microbiol Immunol; 2012 Apr; 56(4):245-53. PubMed ID: 22289120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of
    Bano L; Tonon E; Drigo I; Pirazzini M; Guolo A; Farina G; Agnoletti F; Montecucco C
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29921757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.